Journal of Microbiology, Immunology and Infection (Jun 2020)

Lopinavir/ritonavir did not shorten the duration of SARS CoV-2 shedding in patients with mild pneumonia in Taiwan

  • Chien-Yu Cheng,
  • Yu-Lin Lee,
  • Cheng-Pin Chen,
  • Yi-Chun Lin,
  • Chun-Eng Liu,
  • Chia-Hung Liao,
  • Shu-Hsing Cheng

Journal volume & issue
Vol. 53, no. 3
pp. 488 – 492

Abstract

Read online

An increase of Ct values was 0.9 per day in 2 cases of COVID-19 treated with lopinavir/ritonavir (LPV/r), an increase was 1.0 per day in 3 cases without LPV/r through illness day 1–10, indicating that LPV/r did not shorten the duration of SARS CoV-2 shedding.

Keywords